CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Historical Holders from Q1 2014 to Q1 2025

Symbol
CORT on Nasdaq
CUSIP
218352102
Type / Class
Equity / Common Stock
Shares outstanding
105M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
84.2M
Holdings value
$4.24B
% of all portfolios
0.007%
Grand Portfolio weight change
0%
Number of holders
364
Number of buys
177
Number of sells
-148
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12.7% $1.52B 13.3M BlackRock, Inc. Mar 31, 2025
INGALLS & SNYDER LLC 7.8% $934M 8.17M INGALLS & SNYDER LLC Dec 31, 2024
BELANOFF JOSEPH K 6.3% $779M 6.82M Joseph K. Belanoff Dec 31, 2024

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 5.52M $396M -$61M $114.22 53
2024 Q4 84.2M $4.24B -$144M $50.39 364
2024 Q3 87.1M $4.03B -$44M $46.28 319
2024 Q2 89.2M $2.9B -$102M $32.49 285
2024 Q1 92.8M $2.34B +$175M $25.19 288
2023 Q4 84.7M $2.75B +$86.2M $32.48 268
2023 Q3 82.2M $2.24B +$50.5M $27.25 241
2023 Q2 80.7M $1.8B -$140M $22.25 221
2023 Q1 87.3M $1.89B +$89.8M $21.66 231
2022 Q4 83.4M $1.69B -$55.2M $20.31 239
2022 Q3 85.4M $2.19B +$74.8M $25.64 218
2022 Q2 83.5M $1.96B +$67.6M $23.78 208
2022 Q1 81.1M $1.83B +$18.3M $22.52 208
2021 Q4 80.5M $1.59B -$6.67M $19.80 196
2021 Q3 80.9M $1.59B +$5.51M $19.68 195
2021 Q2 80.5M $1.77B -$29.8M $22.00 195
2021 Q1 81.3M $1.93B -$39.9M $23.79 205
2020 Q4 81.7M $2.14B -$132M $26.16 216
2020 Q3 89.2M $1.55B +$5.23M $17.40 214
2020 Q2 89.6M $1.51B +$28.4M $16.82 214
2020 Q1 85.9M $1.02B -$19.9M $11.89 191
2019 Q4 89.1M $1.08B +$45.5M $12.10 199
2019 Q3 84.1M $1.19B +$2.45M $14.13 186
2019 Q2 85.8M $957M +$2.16M $11.15 174
2019 Q1 87.1M $1.02B -$45.4M $11.74 198
2018 Q4 90.6M $1.21B +$18.9M $13.36 210
2018 Q3 89.6M $1.26B +$21.6M $14.02 199
2018 Q2 87M $1.37B +$15.7M $15.72 207
2018 Q1 86.5M $1.42B -$23.3M $16.45 203
2017 Q4 88.6M $1.6B +$259M $18.06 181
2017 Q3 73.8M $1.42B +$85.4M $19.30 186
2017 Q2 69.6M $822M +$109M $11.80 152
2017 Q1 60.7M $665M +$148M $10.96 132
2016 Q4 53.3M $387M +$44.1M $7.26 137
2016 Q3 47.2M $307M +$9.9M $6.50 111
2016 Q2 45.7M $250M +$14.8M $5.46 109
2016 Q1 33.9M $158M -$1.02M $4.68 95
2015 Q4 34.1M $170M -$118K $4.98 95
2015 Q3 34.3M $129M +$5.2M $3.76 94
2015 Q2 31.9M $192M +$11.9M $6.01 78
2015 Q1 30.3M $170M +$9.77M $5.60 60
2014 Q4 28.6M $85.9M -$1.42M $3.00 49
2014 Q3 29.3M $78.6M -$1.07M $2.68 53
2014 Q2 29.7M $83.2M -$5.49M $2.80 60
2014 Q1 30.4M $133M +$11.1M $4.36 58